Literature DB >> 26876501

Clinicopathological correlates of depression in early Alzheimer's disease in the NACC.

Sarah T McCutcheon1, Dingfen Han2, Juan Troncoso3, Vassilis E Koliatsos2,3,4, Marilyn Albert4, Constantine G Lyketsos2, Jeannie-Marie S Leoutsakos2.   

Abstract

OBJECTIVE: Depression may be a prodrome to Alzheimer's disease (AD). We assessed whether AD neuropathology is associated with depression in mild cognitive impairment (MCI) and mild dementia (dAD).
METHODS: All clinical and neuropathological data for this study came from the National Alzheimer's Coordinating Center (NACC). Healthy control (HC, n = 120), MCI (n = 77), and mild dAD (n = 93) patients who underwent brain autopsy were included. In regression models with Geriatric Depression Scale (GDS) as the outcome, neuritic plaque (NP) score or Braak Stages of neurofibrillary (NF) pathology were covariates.
RESULTS: GDS was not associated with cognitive status, NP score, Braak Stages, or their interaction. In both models, a history of TIAs, depression within the last 2 years, current benzodiazepine use, and greater severity of neuropsychiatric symptoms were associated with greater depression. In the Braak Stages model, less education was another significant predictor.
CONCLUSIONS: Depression in early AD appears to be independent of NP and NF pathology. Studies are needed to investigate other mechanisms that may be responsible for depression in MCI and dAD.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer's disease; dementia; late-life depression; mild cognitive impairment; neuropathology; neuropsychiatric symptoms

Mesh:

Year:  2016        PMID: 26876501      PMCID: PMC4983531          DOI: 10.1002/gps.4435

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  49 in total

1.  Sertraline for the treatment of depression in Alzheimer disease.

Authors:  Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine Frangakis; Jacobo E Mintzer; Daniel Weintraub; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2010-02       Impact factor: 4.105

2.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian S Appleby; Esther S Oh; Yonas E Geda; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

3.  Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression.

Authors:  V Dhikav; M Sethi; K S Anand
Journal:  Br J Radiol       Date:  2014-07-25       Impact factor: 3.039

4.  Frontal lobe hypometabolism and depression in Alzheimer's disease.

Authors:  N Hirono; E Mori; K Ishii; Y Ikejiri; T Imamura; T Shimomura; M Hashimoto; H Yamashita; M Sasaki
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

5.  Serotoninergic neurites in senile plaques in cingulate cortex of aged nonhuman primate.

Authors:  C A Kitt; L C Walker; M E Molliver; D L Price
Journal:  Synapse       Date:  1989       Impact factor: 2.562

6.  Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers.

Authors:  Kyle Steenland; Conny Karnes; Ryan Seals; Claudine Carnevale; Adriana Hermida; Allan Levey
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

7.  Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.

Authors:  Wei Qiao Qiu; Haihao Zhu; Michael Dean; Zhiheng Liu; Linh Vu; Guanguang Fan; Huajie Li; Mkaya Mwamburi; David C Steffens; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-06       Impact factor: 3.485

8.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

9.  Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis.

Authors:  Scott A Lyness; Chris Zarow; Helena C Chui
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

Review 10.  Depression in Alzheimer's disease: overview and treatment.

Authors:  Constantine G Lyketsos; Jason Olin
Journal:  Biol Psychiatry       Date:  2002-08-01       Impact factor: 13.382

View more
  7 in total

1.  Impact of white matter hyperintensity location on depressive symptoms in memory-clinic patients: a lesion–symptom mapping study

Authors:  Anna E. Leeuwis; Nick A. Weaver; J. Matthijs Biesbroek; Lieza G. Exalto; Hugo J. Kuijf; Astrid M. Hooghiemstra; Niels D. Prins; Philip Scheltens; Frederik Barkhof; Wiesje M. van der Flier; Geert Jan Biessels
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

Review 2.  The enigma of vascular depression in old age: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-15       Impact factor: 3.850

3.  Weight Rich-Club Analysis in the White Matter Network of Late-Life Depression with Memory Deficits.

Authors:  Naikeng Mai; Xiaomei Zhong; Ben Chen; Qi Peng; Zhangying Wu; Weiru Zhang; Cong Ouyang; Yuping Ning
Journal:  Front Aging Neurosci       Date:  2017-08-23       Impact factor: 5.750

4.  Vascular depression consensus report - a critical update.

Authors:  Howard J Aizenstein; Andrius Baskys; Maura Boldrini; Meryl A Butters; Breno S Diniz; Manoj Kumar Jaiswal; Kurt A Jellinger; Lev S Kruglov; Ivan A Meshandin; Milija D Mijajlovic; Guenter Niklewski; Sarah Pospos; Keerthy Raju; Kneginja Richter; David C Steffens; Warren D Taylor; Oren Tene
Journal:  BMC Med       Date:  2016-11-03       Impact factor: 8.775

Review 5.  Mechanisms and treatment of late-life depression.

Authors:  George S Alexopoulos
Journal:  Transl Psychiatry       Date:  2019-08-05       Impact factor: 6.222

6.  Default mode network dissociation linking cerebral beta amyloid retention and depression in cognitively normal older adults.

Authors:  Sheng-Min Wang; Nak-Young Kim; Yoo Hyun Um; Dong Woo Kang; Hae-Ran Na; Chang Uk Lee; Hyun Kook Lim
Journal:  Neuropsychopharmacology       Date:  2021-06-22       Impact factor: 7.853

7.  Neurogranin and BACE1 in CSF as Potential Biomarkers Differentiating Depression with Cognitive Deficits from Early Alzheimer's Disease: A Pilot Study.

Authors:  Carola G Schipke; Ann De Vos; Manuel Fuentes; Dirk Jacobs; Eugeen Vanmechelen; Oliver Peters
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.